Skip to main content
Log in

Studying the Toxic Effects of Some Biologically Active Peptides on the Model of Mouse Embryonic Stem Cells

Bulletin of Experimental Biology and Medicine Aims and scope

Cite this article

We studied the effects of peptide drugs (HLDF-6, PGP, RPGP, and PGLP) and peptide pharmaceutical products (Semax, Selank, and thyroliberin) on proliferation and survival of mouse embryonic stem cells and their derivatives. Differentiation of mouse embryonic stem cells into neuronal precursors was evaluated. PGP and PGLP in concentrations of 10 and 0.1 μM, respectively, had little, but significant inhibitory effect on proliferative activity of cells. These peptides in concentrations of 10 and 0.1 μM, respectively, and Semax (10 and 0.1 μM) significantly increased the survival rate of mouse embryonic stem cells (serum deprivation). Moreover, study peptides had little effect on the formation of neuronal precursors from mouse embryonic stem cells. HLDF-6, Selank, and thyroliberin produced an insignificant effect on the differentiation of these cells into mature neurons. Analysis of differentiation of embryonic stem cells into GABA+ neurons showed that Selank, thyroliberin (100 μM), and NGF (100 ng/ml) decrease the ratio of these cells by 61, 58, and 87%, respectively, in comparison with the control. Our results indicate that these peptide compounds do not produce toxic effect during the embryonic and fetal period of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions


  1. Antonov SA, Manuilova ES, Dolotov OV, Kobylyanskii AG, Kostrov SV, Safina DR, Khaidarova NV, Grivennikov IA. Derivation of mouse embryonic stem cells with inducible expression of human nerve growth factor. Vestn. Biotekhnol. Fiziko-Khim. Biol. Yu. A. Ovchinnikova. 2012;8(3):5-12. Russian.

    Google Scholar 

  2. Grivennikov IA. Embryonic stem cells and the problem of targeted differentiation. Uspekhi Biol. Khimii. 2008;48:181-220. Russian.

    Google Scholar 

  3. Grivennikov IA, Dolotov OV, Inozemtseva LS, Antonov SA, Kobylyanskii AG, Myasoedov NF. The use of primary cultures of mammalian nerve and glial cells for selection of compounds with neuroprotective activity. Vestn. Biotekhnol. Fiziko-Khim. Biol. Yu. A. Ovchinnikova. 2011;7(2):24-31. Russian.

    Google Scholar 

  4. Danlybaeva GA, Zhylkibaev AA, Rykov VA, Tritek VS, Silaev DV, Gylyaev AE. Cytotoxicity of carboranyl-containing compounds. Biotekhnologiya. Teoriya Praktika. 2012;(3):49-54. Russian

  5. Kostanyan IA, Storozheva ZI, Semenova NA, Lipkin VM. Postischemic administration of HLDF-6 peptide ameliorates cognitive dysfunction and brain damage induced by chronic cerebral ischemia in rats. Dokl. Biol. Sci. 2009;428:418-422.

    Article  CAS  PubMed  Google Scholar 

  6. Lyapina LA, Grigor’eva ME, Shubina TA, Myasoedov NF, Andreeva LA. The modern concept of the regulatory role of peptides of the glyproline family in the correction of hemostasis system function during development of diabetes mellitus. Biol. Bull. 2013;40(4):386-393.

  7. Myasoedov NF, Andreeva LA, Lyapina LA, Shubina TA, Grigor’eva ME, Obergan TY. Correction of impairments in functions an organism by the regulatory peptide Leu-Pro-Gly-Pro. Biol. Bull. 2013;40(3):304-306.

  8. Sysoyeva GM, Danilenko YeD, Мasycheva VI, Samoukov VV, Коstanyan IA. Effect of HLDF6 peptide on splenocyte proliferation in vitro in the setting of opiate receptor agonists. Sib. Med. Zh. (Tomsk). 2009;24(4-1):55-59. Russian.

  9. Barbierato M, Argentini C, Skaper SD. Indirect immunofluorescence staining of cultured neural cells. Methods Mol. Biol. 2012;846):235-246.

  10. Cai C, Grabel L. Directing the differentiation of embryonic stem cells to neural stem cells. Dev. Dyn. 2007;236(12):3255-3266.

  11. Cattaneo E, McKay R. Proliferation and differentiation of neuronal stem cells regulated by nerve growth factor. Nature. 1990;347:762-765.

    Article  CAS  PubMed  Google Scholar 

  12. Krug AK, Kolde R, Gaspar JA, Rempel E, Balmer NV, Meganathan K, Vojnits K, Baquié M, Waldmann T, Ensenat-Waser R, Jagtap S, Evans RM, Julien S, Peterson H, Zagoura D, Kadereit S, Gerhard D, Sotiriadou I, Heke M, Natarajan K, Henry M, Winkler J, Marchan R, Stoppini L, Bosgra S, Westerhout J, Verwei M, Vilo J, Kortenkamp A, Hescheler J, Hothorn L, Bremer S, van Thriel C, Krause KH, Hengstler JG, Rahnenführer J, Leist M, Sachinidis A. Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch. Toxicol. 2013;87(1):123-143.

    Article  CAS  PubMed  Google Scholar 

  13. Stavchansky VV, Yuzhakov VV, Botsina AY, Skvortsova VI, Bondurko LN, Tsyganova MG, Limborska SA, Myasoedov NF, Dergunova LV. The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: a pilot study. J. Mol. Neurosci. 2011;45(2):177-185.

    Article  CAS  PubMed  Google Scholar 

  14. Wobus AM, Löser P. Present state and future perspectives of using pluripotent stem cells in toxicology research. Arch. Toxicol. 2011;85(2):79-117.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to A. G. Kobylyanskii.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 163, No. 6, pp. 696-701, June, 2017

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kobylyanskii, A.G., Zolotarev, Y.A., Andreeva, L.A. et al. Studying the Toxic Effects of Some Biologically Active Peptides on the Model of Mouse Embryonic Stem Cells. Bull Exp Biol Med 163, 731–736 (2017).

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI:

Key Words